Chest Wall Thickness measurements and the dosimetric implications for
male workers in the Uranium Industry.
Gary H. Kramer*, Barry M. Hauck*,
Steve A. Allen1, Tae-Young Lee2, Jong-Il Lee2,
and Si-Young Chang2
*Human Monitoring Laboratory, Radiation
Protection Bureau, 775 Brookfield Road, Ottawa, Ontario, K1A 1C1
(Gary_H_Kramer@hc-sc.gc.ca, www.hc-sc.gc.ca/ncrc/)
1 Department of
Compliance and Licensing, Cameco Corporation, 1 Eldorado Place, Port Hope,
Ontario, Canada L1A 3A1
2 Health Physics Department, Korea Atomic Energy
Research Institute, PO Box 105, Yusong, Taejon, 305-600, Korea.
INTRODUCTION
Chest
wall thickness (CWT) is often estimated by biometric equations; however, as
Vickers (1) has shown, these equations are site specific. Large errors can be introduced into the CWT
estimate, and hence the activity estimate, if a literature equation is simply
applied to a worker population without verification. Health Canada’s Human Monitoring Laboratory (HML), which operates
the National Calibration Reference Centre for In Vivo Monitoring (2), has
measured chest wall thicknesses (CWT) of a representative number of male
workers at Canadian uranium refinery, a conversion plant, and a fuel
fabrication site to derive the appropriate biometric equation. Estimates of the adipose content of the
chest wall was made on a selected group as the adipose mass fraction (AMF) can
have a significant effect on the transmission of low energy photons (3). The HML
has also measured chest wall thicknesses (CWT) of a representative number of
male workers at the Korea Atomic Energy Research Institute (KAERI) to derive
the appropriate biometric equation.
The
CWT data has been used to estimate the sensitivity of lung counting for natural
uranium for a phoswich and germanium based lung counting system. The dosimetric implications have been put
into the perspective that will result from the imminent change to the Canadian
Regulations. This change will result in
a dose limit to 100 mSv in a five-year
period with a maximum of 50 mSv in any one year. An average of 20 mSv per year has been assumed in this paper.
METHODS AND MATERIALS
Ultrasound
Measurements: The HML’s portable ultrasound unit (Aloka
SSD-500 echo camera) used a 5 MHz linear array to make the measurements. Each subject was asked to strip to the
waist. A clear template and a black
marker were used to mark 11 measurement positions on the subject’s chest above
each lung. These positions represented
areas of the chest that would be measured by both germanium and phoswich
detectors. The ultrasound probe was
covered with Aquasonic 100 gel prior to application to the subject’s
chest. The gel was reapplied to the
probe whenever signal loss prevented a clear being obtained on the
ultrasound unit.
An
estimate of the AMF was also made from selected ultrasound images taken at the
conversion facility and at the refinery by measuring the thicknesses of the fat
and the muscle layers in the imaged chest wall using the instruments internal
calipers. Estimates of the AMF were
also made at each measurement point on the subjects measured at the fuel
fabrication site.
Canada: Eighty five male subjects at a uranium conversion facility were
measured in a sitting geometry simulating the position of a germanium lung
counter. Thirty-five male
subjects were measured at a uranium
refinery and eleven male subjects were measured at a fuel fabrication
plant. The latter two groups were
measured in a sitting and a supine position.
The supine position simulates the counting position in the phoswich
based lung counting system used by the company.
Korea:
A clear template and a black marker were used to mark 14 measurement
positions on the subject’s chest above each lung. These positions represented areas of the chest that would be
measured by KAERI’s germanium detectors. One hundred and twenty one male
subjects were measured in a supine geometry simulating the counting position of
a germanium lung counter.
COUNTER CALIBRATIONS
Lung Counter:
The lung counting system at KAERI, supplied by Canberrra, consists of
two ACTII units. Each unit contains two
Ge detectors (50 mm diameter, 20 mm thick, 0.5 mm Be window) cooled by one
Dewar. Each two-detector unit is fitted with a graded shield consisting of 1.0
cm lead and 0.32 cm of copper to reduce background. The units are mounted in a Model 2275 dual purpose lung and whole
body counter chamber, constructed of 10 cm thick low background steel, lined
with stainless steel. Spectra acquired
with the Ge detectors are stored and analysed using ABACOS-PC software.
Lung Counter
Calibration: The
lung counter had been previously calibrated by KAERI staff using the LLNL torso
phantom with and without the B-series overlay plates. These plates simulate 50% adipose and 50% muscle so that when
they are added to the chest plate, which is 0% adipose, the following adipose
contents can be simulated: 0%, 15%,
21%, 26% and 30%. The KAERI lung
counting efficiency has been fitted to adipose mass fraction, CWT, and photon
energy as described elsewhere. The LLNL
torso phantom containing 701 mg of natural uranium homogeneously distributed
throughout the lung substitute material was used to estimate the counting
efficiency of both the phoswich and the Ge lung counting systems. The phantom was counted with and without the
C-series overlay plates to simulate 100% muscle and thereby give counting
efficiency as a function of muscle-equivalent-chest wall thickness directly.
Phoswich
Lung Counter: The phoswich lung counter consists of a low background
monitoring chamber, a phoswich detector assembly and multichannel analyzer, all
enclosed in a 12.2 meter air conditioned transport trailer. The counting chamber is constructed of 10.2
cm thick selected low background steel with a 3 mm lead liner. The interior dimensions are: 213 cm long, 132 cm high and 76 cm
deep. Subjects are counted in a supine
position using detectors positioned both above and below the chest cavity.
The lung counter consists of four phoswich detectors. Each detector consists of a NaI(Tl) crystal
(12.5 cm diameter; 1.25 cm thick) optically coupled to a CsI(Na) crystal (12.5
cm diameter; 5.1 cm thick optically coupled to a photomultiplier tube. The phoswich detectors are connected through
a multiplexer to a microcomputer based multichannel analyzer. The multichannel analyzer functions are
controlled by the microcomputer, which also performs the data analysis and
storage. Data were analyzed for the
front two-detector arrays only.
Germanium
lung counter: The HML’s germanium lung counting system
consists of four large area germanium detectors supplied by EG&G
Ortec. Each detector, which is cooled
by a 17 liter Dewar, is 70 mm in diameter and 30 mm thick. The beryllium entrance window is 0.5 mm
thick. The detectors are housed in a counting chamber that is constructed of 20
cm thick low background steel. The
shield’s interior is covered with a lead liner that is approximately 0.6 cm
thick. Spectra acquired from the
individual Ge detectors were summed and analyzed as an array.
Background Measurements: The background count used for the MDA
estimate of the Ge lung counter was obtained from the spectrum of an
uncontaminated person who was measured for 1800 seconds in the HML’s lung
counter. The counts in the appropriate spectral region of interest were used
with the appropriate calibration factor for that energy. Units of MDA will depend on the units of
the calibration factor and the counting time.
For natural uranium, the HML uses both Bq and milligrams. The following formula is based on the work
of Currie (5), with Brodsky’s (6) modification:
|
Where: N = background counts in
the region of interest, E = counting efficiency (cps Bq-1 or cps mg-1), T = counting time
(sec).
Similarly,
the background count used for the MDA estimate of the phoswich lung counter was
obtained by measuring an uncontaminated person for 1800 seconds who was of
comparable size to the average worker.
It is recognised that background, especially in a phoswich lung counter,
varies with the individual’s size; however, to build in a size dependent
background is beyond the scope of this work. It is suggested that readers
applying this methodology measure a range of physical types to characterise
their counting systems.
Korea:
The lung counting system at KAERI, supplied by Canberrra, consists of
two ACTII units. Each unit contains two
Ge detectors (50 mm diameter, 20 mm thick, 0.5 mm Be window) cooled by one
Dewar. Each two-detector unit is fitted with a graded shield consisting of 1.0 cm
lead and 0.32 cm of copper to reduce background. The units are mounted in a Model 2275 dual purpose lung and whole
body counter chamber, constructed of 10 cm thick low background steel, lined
with stainless steel. Spectra acquired
with the Ge detectors are stored and analysed using ABACOS-PC software.
The lung counter had been previously
calibrated by KAERI staff using the LLNL torso phantom with and without the
B-series overlay plates. These plates
simulate 50% adipose and 50% muscle so that when they are added to the chest
plate, which is 0% adipose, the following adipose contents can be
simulated: 0%, 15%, 21%, 26% and
30%. The KAERI lung counting efficiency
has been fitted to adipose mass fraction, CWT, and photon energy as described
elsewhere. The background counts used
for the MDA estimate of the Ge lung counter were obtained from the spectra of
five uncontaminated persons who were measured for 1800 seconds in the KAERI’s
lung counter. The counts in the appropriate spectral region of interest were
used with the appropriate calibration factor for that energy.
RESULTS AND DISCUSSION
Ultrasound Measurements: Comparison of the data collected in the
germanium detector counting regions with that of the phoswich region showed no
difference in the mean chest wall thickness: a t-test showed that the null
hypothesis (no difference between means) was accepted. Results of the t-test for each site were
0.0014, 4.1 x10-5, and 0.027.
Each site was then compared using ANOVA. The F value was 0.68 which is less than the value of F(2,133) indicating that the null hypothesis
is accepted. The Canadian data has,
therefore, been kept as a single set.
The eleven measurement points on both left and right lungs were averaged
to give an average chest wall thickness above each lung. The twenty two points were also combined and
averaged to give an average chest wall thickness for a lung counting detector
array - this data are reported here.
The
grand average of a male supine subject was 3.73 cm. The supine posture used in the facility’s lung counter increased
the average CWT by about 0.3 cm to 0.5 cm.
This observation agrees with earlier work (7) and shows that there will
be a decrease in counting efficiency compared to a seated geometry;
consequently, there will be an increase in the minimum detectable activity
(MDA).
The
AMF of the chest wall of conversion plant and refinery workers lies in the
range 5% to 40% with a mean of 22%. The
fuel fabrication workers had a mean AMF of 21 " 6%. The range of the mean AMF was 17% to 28%, but individual
measurement points on the workers’ chest were found to vary from 4% to
42%. This data seems comparable to the
literature data - see Table 2.
Comparison of these data with other literature data (1,7,8) indicate
that the uranium refinery, conversion plant, and fuel fabrication workers have
larger CWT values. Unfortunately this
can not be statistically tested as there are insufficient literature data to
make the comparison.
The
Korean site specific data for the average, standard deviation of a single
measurement, standard deviation of the mean, the median, the maximum, and the
minimum of Age, Height, Weight, and CWT were collected for 121 KAERI workers.
The grand average for male supine subjects was 2.70 cm.
Biometric Equation: Weight, height and
age data that were used to derive an empirical equation to predict CWT. The
largest CWT of 8.29 cm (Canada) has been excluded from this analysis as the
height and weight data were not available for this individual. Linear regression was performed on the data
using the function published elsewhere (8) and shown below:
|
Where: CWT is measured chest
wall thickness (cm), Wt is subject
weight (kg), Ht is subject height
(m), and a, b, and c are the
coefficients of regression.
The
standard error of the Canadian data indicates that 68% of the predicted CWT
values will be within 0.5 cm, 95% within 1 cm, and 99% within 1.5 cm. The standard error of the Korean data
indicates that 68% of the predicted CWT values will be within 0.28 cm, 95%
within 0.56 cm, and 99% within 0.84 cm. These findings support the rationale
that the biometric equation be only used for routine counting and that
ultrasound measurements be used to determine an accurate CWT in case of a
positive lung burden being discovered.
Implications for MDA - Germanium counting: Although the higher energy (185 keV) photons
of 235U are less attenuated than the 63 keV photons from 234
Th, the combination of the low natural
abundance (0.712%), branching ratio (54%), and decreased counting efficiency as
a function of CWT interact to slightly increase the MDA, relative to 234 Th
for the Canadian data and the opposite for the Korean data..
Canada: Given that the range of CWT values is 1.9 cm to
about 8 cm, the achievable range of MDA’s is about 8 mg to 57 mg of natural
uranium using photons emitted from 235U (although a slight
improvement can be obtained by measuring the photons emitted from 234Th,
they cannot be used for reasons given below).
The grand average CWT is 3.7 cm so the corresponding MDA will be about
14 mg. Doubling the counting time to 60
minutes will reduce the MDA to about 10 mg of natural uranium.
Korea:
Given that the range of CWT values is 1.9 cm to about 4.1 cm, the
achievable range of MDA’s is about 6.6 mg to 13.2 mg of natural uranium using
photons emitted from 235U (although a slight improvement can be
obtained by measuring the photons emitted from 234Th, they cannot be
used for reasons given below). The
grand average CWT is 2.7 cm so the corresponding MDA will be about 8.5 mg. Doubling the counting time to 60 minutes
will reduce the MDA to about 6 mg of natural uranium.
Implications for MDA - Phoswich counting: Certain assumptions have been made in
obtaining these data: count data were
obtained for fixed regions of interest, and background correction is performed
by matched subject counting. The data
show that the phoswich detectors used in this study have a lower MDA for
natural uranium if it is estimated from the 63 keV photopeak emitted from the
daughter product 234 Th compared to the MDA values estimated from
the 185 keV photons emitted by 235U; however, this assumes that the
daughter (24 day half-life) is in equilibrium with the parent 238U. If the equilibrium is not established, then natural
uranium must be estimated from the 235U photopeak and the accuracy
of this estimate depends on the mass composition of natural uranium. An uncertainty will be introduced into the
activity estimate if any enrichment or depletion has occurred during
refinement.
Lung
counting of uranium refinery, conversion plant, and fuel fabrication workers
for natural uranium assumes that daughter equilibrium has not been
established. Lung burdens are,
therefore, determined from the 185 keV photons emitted by 235U. The two-detector-phoswich array is more
sensitive than the germanium detector array.
For example, at a muscle-equivalent-chest-wall-thickness of 4 cm the
phoswich array’s MDA (235U) is approximately 12 mg whereas the
germanium array’s MDA (235U) is about 15 mg.
Dosimetric implications: Table 1 shows
the expected lung burden at various times following an intake of either 428 mg or 128 mg (the Annual Limit on
Intake for Type M and S, i.e., that amount of activity that will give a
committed effective dose of 20
mSv). The values were calculated from
data published elsewhere (9). Type F
was not considered as it will not be retained in the lung and should be part of
a urinalysis bioassay program.
Four
intake scenarios were investigated: one day before a lung count, seven days
before a lung count, six months before a lung count, and one that occurred just
after the last lung count, assuming an annual frequency.
Canada: Consider a hypothetical individual who has a
CWT equal to the average value (3.7 cm, AMF 30%) has an intake in each time
scenario. The hypothetical individual
is measured using a phoswich array lung counter and the activity estimate is
based on 235U. Type M
intake: it will be readily detected on days 1 and 7; however, as the MDA for a 30 minute count time is 10.8 mg,
days 180 and 360 will be missed. If the counting time is increased to 60
minutes the MDA would be expected to drop to 7.7 mg, and day 180 will be
detected, but not day 360. Type S
intake: days 1 and 7 may be detected if the counting time is 60 minutes, but
days 180 and 365 will be missed as they are well below the MDA.
The
conclusions are not substantially different if the counting system is a
germanium lung counter; however, there are some modifying factors. The CWT of a seated subject is less than
that of a supine subject: the average decrease in the CWT for the workforce was
0.3 cm. This decrease in the CWT will
lower the MDA slightly but not sufficient to make any substantial difference in
the level of detection and the conclusions presented below. The hypothetical individual is now measured
using a germanium array lung counter and the activity estimate is based on 235U. Type M:
days 1, and 7 would be detected, but not days 180 and 360 - there is no
change in this finding even if the counting time is increased to 60
minutes. Type S: days 1, 7, 180 and 365
will be missed as they are below the MDA.
Similarly, there is no change if the counting time is increased to 60
minutes.
For
countries using earlier ICRP recommendations and a dose limit of 50 mSv/y the
situation is somewhat different. The
values in Table 1 would be multiplied by 2.5 and then compared against the MDA
values in tables 6 and 7. Under these
circumstances the hypothetical individual would have a Type M or S intake
detected by a phoswich lung counter or a Ge lung counter for days 1, 7, 180 and
360 if the counting time was 60 minutes.
Korea: Consider that a hypothetical individual, who has a CWT equal
to the average value (2.7 cm) and an AMF of 20%, has an intake in each time
scenario. The hypothetical individual
is measured using the KAERI lung counting Ge detector array and the activity
estimate is based on 235U.
Type M intake: it will be readily detected on days 1, 7 and 180;
however, as the MDA for a 30 minute count time is 8.5 mg, day 360 will be
missed. If the counting time is
increased to 60 minutes the MDA would be expected to drop to 6.0 mg which is
still too high to detect the intake on day 360. Type S intake: no intake will be detected if the counting time is
30 minutes. Days 1 and 7 will be
detected if the counting time is 60 minutes, but days 180 and 365 will be
missed as they are below the MDA.
For
countries using earlier ICRP recommendations and a dose limit of 50 mSv/y the situation
is somewhat different. The hypothetical
individual would have a Type M or S intake detected for days 1, 7, 180 and 360
if the counting time was 30 minutes.
CONCLUSIONS
The
average chest wall thickness of the seated persons measured at the uranium
conversion plant, refinery, and at the fuel fabrication facility was 3.7 cm.
Persons measured in a seated geometry had a thinner chest wall thickness than
persons measured in a supine geometry - the average decrease was 0.3 cm. It follows that a seated geometry will give
a slightly lower MDA (or decision level) than a supine geometry.
Achievable
MDA’s (30 minute counting time) with a two-phoswich-detector array lie in the
range of 6.7 mg to 19.1 mg of natural uranium based on the 235U
emissions over a range of CWT of 1.6 cm to 6.0 cm. The average achievable MDA is about 11 mg which can be reduced to
about 8 mg by doubling the counting time.
Similarly, MDA’s (30 minute counting time) obtainable with a germanium
lung counting system will lie in the range of 7 mg to 30 mg of natural uranium
based on the 235U emissions over a range of CWT of 1.6 cm to 6.0 cm.
The average achievable MDA will be about 14 mg which can be reduced to about 10
mg by doubling the counting time.
The
average chest wall thickness of the supine persons measured at KAERI was 2.7
cm. Achievable MDA’s (30 minute
counting time) with the KAERI lung counting Ge detector array lie in the range
of about 6.6 mg to 13.2 mg of natural uranium based on the 235U
emissions over a range of CWT of 1.9 cm to 4.1 cm. The average achievable MDA is about 8.5 mg which can be reduced
to about 6 mg by doubling the counting time.
Unfortunately,
all of these MDA values are close to, or above, the predicted amounts of
natural uranium that will remain in the lung after an intake equivalent to the
Annual Limit on Intake that corresponds to 20 mSv.
REFERENCES
1 Vickers,
L.R. The gender specific chest wall
thickness prediction equations for routine measurements of 239Pu and
241Am within the lungs using HPGe detectors. Health Phys. 70(3), 346-357 (1996).
2 Kramer,
G.H.; Limson Zamora, M. The Canadian National Calibration Reference
Centre for Bioassay and In-Vivo Monitoring:
A Program Summary. Health
Phys. 67(2), 192-196 (1994).
3 Kruchten,
D.A; Anderson, A.L. Improved ultrasonic
measurement techniques applied to assay of Pu and other transuranics in
lung. Health Phys. 59(1), 117-123
(1990).
4 Griffith R.V., Dean P.N., Anderson
A.L., Fisher J.C. Tissue equivalent torso phantom for intercalibration of in vivo
transuranic nuclide counting facilities.
In: Advances in Radiation Monitoring, Proceedings of an
International Atomic Energy Agency Conference.
IAEA-SM-229/56, 4493-504. (IAEA,
Vienna) (1978).
5 Currie; L.A. Limits for qualitative
detection and quantitative determination:
Application to radiochemistry. Analytical
Chemistry 40, 586-593 (1968).
6 Brodsky, A. Accuracy and detection
limits for bioassay measurements in radiation protection. Report NUREG-1156 (Washington D.C., US
Nuclear Regulatory Commission) (1986).
7 Palmer, H.E.; Rieksts, G.A; Jefferies,
S.J.; Gunston, K.J. Improved counting efficiencies for measuring
239Pu in the lung in the sitting position. Health Phys. 57(5),
747-752 (1989).
8 Summerling, T.J.; Quant, S.P. Measurements
of the human anterior chest wall by ultrasound and estimates of chest wall
thickness for use in determination of transuranic nuclides in the lung. Rad. Prot. Dosim. 3(4), 203-210 (1982).
9 International Commission on
Radiological Protection. Individual Monitoring for internal exposure
of workers. ICRP publication No. 78 (Oxford, Pergamon Press) (1997).
Table 1:
Amount of natural uranium retained (mg) in the lung following an acute intake
of an amount equal to one Annual Limit on Intake (ICRP 1997).
|
Amount retained in the lungs (mg) |
|
Day since intake |
M: (428 mg) |
S: (128 mg) |
1 |
24.8 |
8.2 |
7 |
23.1 |
7.8 |
180 |
9.4 |
4.9 |
360 |
5.1 |
4.1 |